Vibronix

Vibronix is a private medical device company developing imaging and sensing systems for precision healthcare, with a focus on surgical guidance and diagnostic applications. Founded out of Purdue University, the company combines vibrational spectroscopy, optical and acoustic imaging, augmented reality, and machine learning to build integrated tools for disease diagnosis and treatment. Its disclosed products include AcuSee, an FDA 510(k)-cleared guidance system for ultrasound-guided procedures, AcouStar for tumor localization and device tracking, LipoPAT/MarginPAT for intraoperative cancer imaging, and UltraView for multimodal nonlinear optical microscopy. The company appears to operate as a healthcare imaging and diagnostics platform company rather than a therapeutics developer. Vibronix has raised venture funding, including a 2024 Series A+/A1 financing, and remains privately held and active.